Treace Medical Concepts (TMCI) Cash from Operations (2020 - 2026)

Treace Medical Concepts' Cash from Operations history runs 7 years deep, the most recent figure standing at 7240000.0 for Q1 2026.

• Quarterly Cash from Operations rose 72.46% year-over-year to 7240000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12928000.0 (up 49.79% YoY) and the FY2025 annual result came in at 15970000.0, up 57.03% from the prior year.
• Cash from Operations was 7240000.0 for Q1 2026 at Treace Medical Concepts, up from 8026000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 7240000.0 in Q1 2026 and bottomed at 17259000.0 in Q1 2023.
• A 5-year average of 6536470.59 and a median of 7490000.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations slumped 1523.54% — and 2025, when it surged 158.14%.
• Treace Medical Concepts' Cash from Operations stood at 5358000.0 in 2022, then surged by 109.93% to 532000.0 in 2023, then slumped by 890.79% to 4207000.0 in 2024, then slumped by 90.78% to 8026000.0 in 2025, then surged by 190.21% to 7240000.0 in 2026.
• Business Quant data shows TMCI's Cash from Operations at 7240000.0 in Q1 2026, 8026000.0 in Q4 2025, and 9092000.0 in Q3 2025.